Business Wire

Merck Animal Health Receives Positive CVMP Opinion for an Injectable Formulation of BRAVECTO ® (Fluralaner) for Use in Dogs

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Fox Business

Blockbuster long acting flea and tick treatment for dogs coming after FDA approval

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA). The approval of the new injectable ...
Business Wire

Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
KTVU

What is Bravecto Quantum? FDA approves 12-month flea and tick treatment

Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...
ABC7

FDA approves long-acting flea treatment for dogs, marking veterinary breakthrough

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
Pharmabiz

EMA committee recommends approval of Merck Animal Health’s injectable formulation of Bravecto for use in dogs

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., announced that the European Medicines Agency’s Committee for Veterinary ...